Skip to main content
 

Market Access: how the UK is transforming Pharmaceutical Access

21 Dec 2022 13:00 - 14:00

Market Access: how the UK is transforming Pharmaceutical Access
Click to enlarge

A pharmaceutical market access specialist with more than 20 years’ experience of tracking access environments around the world. 

Scott McKenzie on LinkedIn

more about Neil
FREE CHRISTMAS REPLAY

The UK is one of Europe’s largest markets but has long had the unenviable reputation of being “low and slow” for the uptake of new medicines. In recent months, however, the government has introduced ground-breaking measures to expedite access. The regulatory and health technology assessment (HTA) agencies have been working with the NHS to develop innovative approaches to make promising new drugs widely available without delay.  

These changes are helping to make the UK one of the most inventive access environments in Europe, with a willingness to explore new ideas in partnership with pharmaceutical companies. 

Join Ian Chamberlain and Neil Grubert, a Market Access Specialist,  and discover what you can learn from the UK experience.

 

Register using the form below: